Cambridge Investment Research Advisors’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $305K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $285K | Sell |
|
|||||
|
2022
Q2 | $360K | Sell |
|
|||||
|
2022
Q1 | $590K | Buy |
|
|||||
|
2021
Q4 | $454K | Buy |
|
|||||
|
2021
Q3 | $379K | Buy |
|
|||||
|
2021
Q2 | $595K | Sell |
|
|||||
|
2021
Q1 | $849K | Buy |
|
|||||
|
2020
Q4 | $781K | Buy |
|
|||||
|
2020
Q3 | $623K | Buy |
|
|||||
|
2020
Q2 | $320K | Buy |
|
|||||
|
2020
Q1 | $290K | Sell |
|
|||||
|
2019
Q4 | $280K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $1.02M | Buy |
|
|||||
|
2018
Q3 | $1.08M | Sell |
|
|||||
|
2018
Q2 | $1.21M | Buy |
|
|||||
|
2018
Q1 | $805K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $674K | Buy |
|